Ahmed Nazzal
- Global Health and Surgery
- Cardiac, Anesthesia and Surgical Outcomes
- Uterine Myomas and Treatments
- Endometrial and Cervical Cancer Treatments
- Health and Medical Research Impacts
- COVID-19 and healthcare impacts
- Animal testing and alternatives
- COVID-19 diagnosis using AI
- Endometriosis Research and Treatment
- Ethics in Clinical Research
- Colorectal Cancer Screening and Detection
- Artificial Intelligence in Healthcare
Mansoura University
2018-2022
Ministry of Health
2021
Imperial College London
2018
University of Edinburgh
2018
The aim was to study the incidence and survival of patients with uterine sarcoma diagnosed in period from 2000 2012 based on Surveillance, Epidemiology, End Results (SEER) database.All 18 registries SEER database were used select cases. We included women aged 30 years or older sarcoma. Histological subtypes defined as leiomyosarcoma, carcinosarcoma, stromal sarcoma, adenosarcoma, not otherwise specified according 2003 World Health Organization classification. Using SEER*Stat software version...
Abstract The ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines are widely endorsed but compliance is limited. We sought to determine whether journal-requested completion an checklist improves full with the guidelines. a randomised controlled trial, manuscripts reporting in vivo animal research submitted PLOS ONE (March-June 2015) were allocated either requested or current standard practice. measured change proportion meeting all guideline items between groups. 1,689...
Throughout the global coronavirus pandemic, we have seen an unprecedented volume of COVID-19 researchpublications. This vast body evidence continues to grow, making it difficult for research users keep up with pace evolving findings. To enable synthesis this timely use by researchers, policymakers, and other stakeholders, developed automated workflow collect, categorise, visualise from primary studies. We trained a crowd volunteer reviewers annotate studies relevance COVID-19, study...
Background: This study aims to identify causes of death among vulvar cancer patients diagnosed in the period between 2004 and 2013, using Surveillance, Epidemiology, End-Results (SEER) Program.Patients Methods: Data 3769 Women with cancer, aged 40 years or more were extracted.Causes categorized into death, other death.The statistical analysis was performed R (Version 3.4.0)utilizing survival package 2.41-3) competing for risk package.Results: At end follow-up period, 2520 (66.9%) alive while...